Enveric Biosciences (ENVB) Stock Surges on Patent Win: News, Forecast & Analysis as of December 10, 2025
Enveric Biosciences, Inc. has suddenly jumped back onto traders’ screens. After closing regular trading on Tuesday, December 9, at about $5.92, the stock ripped more than 70% in after‑hours trading to around $10.29, driven by a fresh U.S. patent win for one of its key drug programs. Benzinga+2StockAnalysis+2 Pre‑market feeds early on December 10 show ENVB up roughly 77% to around $10.48 on StockAnalysis’ screener, while a separate live quote stream cited the name closer to $12.45, underlining just how chaotic price discovery is in this ultra‑thin micro‑cap. TechStock²+1